DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Jones SE, Collea R, Paul D, Sedlacek S, Favret AM, Gore IJr. et al
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: A single-group, open-label, phase 2 study.
Lancet Oncol 2013;
14: 1121-8
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.